Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Monalizumab: inhibiting the novel immune checkpoint NKG2A.

van Hall T, André P, Horowitz A, Ruan DF, Borst L, Zerbib R, Narni-Mancinelli E, van der Burg SH, Vivier E.

J Immunother Cancer. 2019 Oct 17;7(1):263. doi: 10.1186/s40425-019-0761-3. Review.

2.

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E.

Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29. Review.

3.

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.

Vey N, Karlin L, Sadot-Lebouvier S, Broussais F, Berton-Rigaud D, Rey J, Charbonnier A, Marie D, André P, Paturel C, Zerbib R, Bennouna J, Salles G, Gonçalves A.

Oncotarget. 2018 Apr 3;9(25):17675-17688. doi: 10.18632/oncotarget.24832. eCollection 2018 Apr 3.

4.

Cord blood attached segment: is this a relevant quality control to predict a good hematopoietic stem cell graft?

Faivre L, Boucher H, Zerbib R, Domet T, Desproges A, Couzin C, Vanneaux V, Larghero J, Cras A.

Bone Marrow Transplant. 2017 Sep;52(9):1353-1354. doi: 10.1038/bmt.2017.150. Epub 2017 Jul 10. No abstract available.

PMID:
28692031
5.

A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.

Benson DM Jr, Cohen AD, Jagannath S, Munshi NC, Spitzer G, Hofmeister CC, Efebera YA, Andre P, Zerbib R, Caligiuri MA.

Clin Cancer Res. 2015 Sep 15;21(18):4055-61. doi: 10.1158/1078-0432.CCR-15-0304. Epub 2015 May 21.

6.

Predictive factors of survival after thalidomide therapy in advanced multiple myeloma: long-term follow-up of a prospective multicenter nonrandomized phase II study in 120 patients.

Decaux O, Renault A, Sébille V, Moreau P, Attal M, Voillat L, Pegourie B, Tiab M, Facon T, Zerbib R, Grosbois B, Bellissant E; Intergroupe Francophone du Myélome.

Clin Lymphoma Myeloma Leuk. 2012 Dec;12(6):418-22. doi: 10.1016/j.clml.2012.06.003. Epub 2012 Sep 29.

PMID:
23025991
7.

Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial.

Kropff M, Baylon HG, Hillengass J, Robak T, Hajek R, Liebisch P, Goranov S, Hulin C, Bladé J, Caravita T, Avet-Loiseau H, Moehler TM, Pattou C, Lucy L, Kueenburg E, Glasmacher A, Zerbib R, Facon T.

Haematologica. 2012 May;97(5):784-91. doi: 10.3324/haematol.2011.044271. Epub 2011 Dec 1.

8.

Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.

Yakoub-Agha I, Mary JY, Hulin C, Doyen C, Marit G, Benboubker L, Voillat L, Moreau P, Berthou C, Stoppa AM, Maloisel F, Rodon P, Dib M, Pegourie B, Casassus P, Slama B, Damaj G, Zerbib R, Harousseau JL, Mohty M, Facon T; Intergroupe Francophone du Myélome (IFM).

Eur J Haematol. 2012 Mar;88(3):249-59. doi: 10.1111/j.1600-0609.2011.01729.x. Epub 2012 Jan 4.

PMID:
22023551
9.

Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.

Abgrall JF, Guibaud I, Bastie JN, Flesch M, Rossi JF, Lacotte-Thierry L, Boyer F, Casassus P, Slama B, Berthou C, Rodon P, Leporrier M, Villemagne B, Himberlin C, Ghomari K, Larosa F, Rollot F, Dugay J, Allard C, Maigre M, Isnard F, Zerbib R, Cauvin JM; Groupe Ouest-Est Leucémies et Maladies du Sang (GOELAMS).

Haematologica. 2006 Aug;91(8):1027-32.

10.

Anxiolytic activity of melatonin in mice: involvement of benzodiazepine receptors.

Pierrefiche G, Zerbib R, Laborit H.

Res Commun Chem Pathol Pharmacol. 1993 Nov;82(2):131-42.

PMID:
7905658
11.

[Bone augmentation in implant surgery].

Zerbib R, Ouhayoun JP, Freyss G.

J Parodontol. 1991 May;10(2):177-88. French.

PMID:
2072279
12.

Chronic stress and memory: implication of the central cholinergic system.

Zerbib R, Laborit H.

Pharmacol Biochem Behav. 1990 Aug;36(4):897-900.

PMID:
2217520
14.

[The effect of magnetic fields on scar formation of experimental wounds].

Pierrefiche G, Zerbib R, Baron JB, Laborit H.

Acta Belg Med Phys. 1988 Jul-Sep;11(3):137-41. French. No abstract available.

PMID:
3239321
15.

[The value of projection genioplasty using silicone endoprostheses].

Princ G, Slama M, Zerbib R, Vaillant JM.

Rev Stomatol Chir Maxillofac. 1988;89(2):119-21. French.

PMID:
3165546
16.

[Evaluation of 16 severe pharyngo-esophageal caustic stenoses. Value of the anterior approach in an ileo-colic transplant].

Zerbib R, Sarfati E, Celerier M, Tran ba Huy P.

Ann Otolaryngol Chir Cervicofac. 1986;103(8):581-8. French.

PMID:
3827081
17.

[Involvement of the tympanic bone in chronic otitis (44 cases)].

Perrin A, Despreaux G, Candau P, Bré M, Zerbib R, Saliba N, Basset JM, Fleury P.

Ann Otolaryngol Chir Cervicofac. 1985;102(4):229-37. French.

PMID:
4051391
18.

Thee-dimensional organization of tubular and filamentous nuclear inclusions and associated structures in sympathetic neurons as revealed by serial sections and tilting experiments.

Seite R, Vuillet-Luciani J, Zerbib R, Cataldo C, Escaig J, Pebusque MJ, Autillo-Touati A.

J Ultrastruct Res. 1979 Nov;69(2):211-31. No abstract available.

PMID:
226727
19.

Nuclear inclusions in sympathetic neurons: a quantitative and ultrastructural study in the superior cervical and celiac ganglia of the cat.

Seïte R, Zerbib R, Vuillet-Luciani J, Vio M.

J Ultrastruct Res. 1977 Dec;61(3):254-9. No abstract available.

PMID:
599606
20.

[Problem of microtubular accumulation in endoplasmic reticulum cavities. Observations on neurons in sympathetic ganglia].

Zerbib R.

Arch Biol (Liege). 1975;86(3):299-309. French. No abstract available.

PMID:
1227396
21.

[Paracrystalline inclusions in sympathetic neurons in the dog].

Seïte R, Zerbib R.

C R Acad Hebd Seances Acad Sci D. 1970 Sep 21;271(12):1011-4. French. No abstract available.

PMID:
4991290

Supplemental Content

Loading ...
Support Center